Biontech Se ADR (BNTX)
$101.59
4.26 (4.02%)
16:24 EST
BNTX Stock Quote Delayed 30 Minutes
Previous Close
-
Market Cap
-
PE Ratio
-
EPS
-
Volume (Avg. Vol.)
2.86M
Day's Range
97.31 - 104.99
52-Week Range
28.00 - 131.00
Dividend & Yield
N/A (N/A)
BNTX Stock Predictions, Articles, and Biontech Se ADR News
- From InvestorPlace
- From the Web
7 Biotech Stocks To Buy Beyond Covid Vaccine Plays
It’s a relief to know Covid-19 vaccines are on the way. But there are plenty of other great biotechs that have been overlooked in the market frenzy.
The Question to Ask About COVID-19 Vaccine Stocks
The time to pick your horse in the vaccine race was months ago. These stocks were much cheaper before their trials started. Here's where to focus instead.
The 7 Best Coronavirus Vaccine Stocks Still In The Race For A Cure
Buying strong vaccine stocks at the forefront of the scientific race to treat Covid-19 will help any long-term portfolio in 2021.
How to Invest in a Post-COVID World
Buying stocks that have been hit by a serious but solvable problem, can lead to extraordinary gains when things work out positively.
With Pfizer Partnership, BioNTech Stock Should Push Higher
In light of a collaboration with a major drugmaker and a fast-track toward possible FDA approval, BNTX stock is practically irresistible.
Blockchain: How This Next Great Tech Platform Could Help Fight COVID-19
Simply put, blockchain is the safest way to store and transfer information ever created, which makes it ideal for tracking vaccines.
Covid Vaccine Update: How Do the Moderna and Pfizer Coronavirus Vaccines Compare?
With a new Covid vaccine update today, how do the Moderna and Pfizer coronavirus vaccines compare? Dive in here.
4 Stocks to Buy That Reported Stellar Earnings
The earnings season has been mixed. These four stocks to buy reported strong earnings and are likely to be out-performers.
Where to Invest Before the Holiday Season
We’re heading into the seasonally strong time of year, and as Thanksgiving week approaches, it is likely the market will take off. So, if you have any cash to invest, please be invested before Thanksgiving!
5 Companies to Invest in for 2021 as Markets Price in Economy’s Prospects
By
Ian Cooper
After the volatility of 2020, analysts see some calm in the offing. Here are 5 companies to invest in on those prospects.
BioNTech News: 5 Things for BNTX Stock Investors to Know
Shares of BNTX stock are flying on Monday after BioNTech and Pfizer announced extremely positive results from their Covid-19 vaccine trials.
Vaccine News: Pfizer Stock Soars 15% on Coronavirus Trial Results
Pfizer stock is rallying higher Monday on coronavirus vaccine results, and it's taking the rest of the stock market with it.
Avoid Inovio Pharmaceuticals Stock Until the FDA Greenlights Trials
By
Ian Cooper
While I’d like to tell you Inovio Pharmaceuticals is a blood-in-the-streets opportunity, I can’t. Avoid INO stock for now.
BioNTech Investor Fortunes Rise and Fall on Headlines, Pacts and Funding
BNTX stock is a high-risk high-return investment. BioNTech shares will likely to range-trade in the short run.
Pfizer Stock Pops on Vaccine Timeline News, Trial Expansion
Pfizer stock and partner BioNTech are rallying Monday morning on news the two companies could vaccinate Americans before the end of 2020.
Why Novavax Stock is Still a Strong Buy Even After an 800% Move
By
Ian Cooper
While NVAX stock could race higher on news in coming days of its clinical trials results, play this one safe with a trailing stop loss to safeguard any wins you have to date.
4 Catalysts Could Drive Inovio Pharmaceuticals Stock to Near-term Highs
By
Ian Cooper
Inovio Pharmaceuticals remains one of the most undervalued of the vaccine makers. Even after a 455% run higher, INO stock has plenty of upside fueled by plenty of catalysts.
The Top 3 Coronavirus Vaccine Stocks to Consider Right Now
By
Ian Cooper
The race is on for a coronavirus cure as the pandemic sickens millions. These three vaccine stocks are in the investing spotlight right now.
Neon Therapeutics News: NTGN Stock Rockets 38% on BioNTech Deal
Neon Therapeutics (NTGN ) news for Thursday about a $67.00 million deal with BioNTech (BNTX) has NTGN stock soaring on Thursday.

Navellier Ratings
Powered by Portfolio GraderTotal Grade
B
Buy